Cargando…

Efficacy and safety of left atrial appendage closure compared with oral anticoagulation in atrial fibrillation: a meta-analysis of randomized controlled trials and propensity-matched studies

BACKGROUNDS: Two recent randomized controlled trials (RCTs), the PROTECT-AF and the PREVAIL, showed that in atrial fibrillation (AF) patients, left atrial appendage closure (LAAC) is comparable to oral anticoagulants (OAC) in the prevention of stroke and could also possibly reduce mortality. Neverth...

Descripción completa

Detalles Bibliográficos
Autores principales: Franchin, Luca, Piroli, Francesco, Demola, Pierluigi, Mantovani, Francesca, Iannaccone, Mario, Manfredi, Roberto, D’Ascenzo, Fabrizio, Fortuni, Federico, Ugo, Fabrizio, Meucci, Francesco, Navazio, Alessandro, Boccuzzi, Giacomo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565038/
https://www.ncbi.nlm.nih.gov/pubmed/37829693
http://dx.doi.org/10.3389/fcvm.2023.1212161
_version_ 1785118609295540224
author Franchin, Luca
Piroli, Francesco
Demola, Pierluigi
Mantovani, Francesca
Iannaccone, Mario
Manfredi, Roberto
D’Ascenzo, Fabrizio
Fortuni, Federico
Ugo, Fabrizio
Meucci, Francesco
Navazio, Alessandro
Boccuzzi, Giacomo
author_facet Franchin, Luca
Piroli, Francesco
Demola, Pierluigi
Mantovani, Francesca
Iannaccone, Mario
Manfredi, Roberto
D’Ascenzo, Fabrizio
Fortuni, Federico
Ugo, Fabrizio
Meucci, Francesco
Navazio, Alessandro
Boccuzzi, Giacomo
author_sort Franchin, Luca
collection PubMed
description BACKGROUNDS: Two recent randomized controlled trials (RCTs), the PROTECT-AF and the PREVAIL, showed that in atrial fibrillation (AF) patients, left atrial appendage closure (LAAC) is comparable to oral anticoagulants (OAC) in the prevention of stroke and could also possibly reduce mortality. Nevertheless, this net clinical benefit was not confirmed in the most recent RCT comparing LAAC vs. OAC, the PRAGUE-17 trial. AIM: aim of the present study was to evaluate the efficacy and safety of LAAC compared with OAC among available high-quality studies. METHODS: A systematic search of electronic databases (Medline, Scopus, Embase and the Cochrane Library) was performed to identify eligible RCTs and observational studies with propensity score matching (PSM) analysis. PRISMA guidelines were used for abstracting data and assessing data quality and validity. Outcomes of interest were the occurrence of cardiovascular death (CVD), all-cause death, all-type stroke, and major bleedings. RESULTS: A total of 3 RCTs and 7 PMS studies involving 25,700 patients were identified. 12,961 patients received LAAC while 12,739 received OAC therapy. After a median follow-up of 2.6 years (IQR 2–4.4), patients who received LAAC had lower risk of CVD (RR = 0.62; 95%CI, 0.51–0.74, I(2 )= 0%), all-cause death (RR = 0.67; 95% CI, 0.57–0.78, I(2) 68%) and major bleedings (RR = 0.68; 95%CI, 0.48–0.95 I(2 )= 87%) compared with patients on OAC. No difference was found between the two groups regarding strokes incidence (RR = 0.94; 95% CI, 0.77–1.15, I(2 )= 0%). CONCLUSIONS: According to this meta-analysis, LAAC has comparable efficacy in the prevention of stroke compared with OAC and a reduced risk of major bleedings, all-cause death and CVD that may be even larger with longer follow-up. SYSTEMATIC REVIEW REGISTRATION: https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=269768, identifier CRD42021269768.
format Online
Article
Text
id pubmed-10565038
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-105650382023-10-12 Efficacy and safety of left atrial appendage closure compared with oral anticoagulation in atrial fibrillation: a meta-analysis of randomized controlled trials and propensity-matched studies Franchin, Luca Piroli, Francesco Demola, Pierluigi Mantovani, Francesca Iannaccone, Mario Manfredi, Roberto D’Ascenzo, Fabrizio Fortuni, Federico Ugo, Fabrizio Meucci, Francesco Navazio, Alessandro Boccuzzi, Giacomo Front Cardiovasc Med Cardiovascular Medicine BACKGROUNDS: Two recent randomized controlled trials (RCTs), the PROTECT-AF and the PREVAIL, showed that in atrial fibrillation (AF) patients, left atrial appendage closure (LAAC) is comparable to oral anticoagulants (OAC) in the prevention of stroke and could also possibly reduce mortality. Nevertheless, this net clinical benefit was not confirmed in the most recent RCT comparing LAAC vs. OAC, the PRAGUE-17 trial. AIM: aim of the present study was to evaluate the efficacy and safety of LAAC compared with OAC among available high-quality studies. METHODS: A systematic search of electronic databases (Medline, Scopus, Embase and the Cochrane Library) was performed to identify eligible RCTs and observational studies with propensity score matching (PSM) analysis. PRISMA guidelines were used for abstracting data and assessing data quality and validity. Outcomes of interest were the occurrence of cardiovascular death (CVD), all-cause death, all-type stroke, and major bleedings. RESULTS: A total of 3 RCTs and 7 PMS studies involving 25,700 patients were identified. 12,961 patients received LAAC while 12,739 received OAC therapy. After a median follow-up of 2.6 years (IQR 2–4.4), patients who received LAAC had lower risk of CVD (RR = 0.62; 95%CI, 0.51–0.74, I(2 )= 0%), all-cause death (RR = 0.67; 95% CI, 0.57–0.78, I(2) 68%) and major bleedings (RR = 0.68; 95%CI, 0.48–0.95 I(2 )= 87%) compared with patients on OAC. No difference was found between the two groups regarding strokes incidence (RR = 0.94; 95% CI, 0.77–1.15, I(2 )= 0%). CONCLUSIONS: According to this meta-analysis, LAAC has comparable efficacy in the prevention of stroke compared with OAC and a reduced risk of major bleedings, all-cause death and CVD that may be even larger with longer follow-up. SYSTEMATIC REVIEW REGISTRATION: https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=269768, identifier CRD42021269768. Frontiers Media S.A. 2023-09-27 /pmc/articles/PMC10565038/ /pubmed/37829693 http://dx.doi.org/10.3389/fcvm.2023.1212161 Text en © 2023 Franchin, Piroli, Demola, Mantovani, Iannaccone, Manfredi, D'Ascenzo, Fortuni, Ugo, Meucci, Navazio and Boccuzzi. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Franchin, Luca
Piroli, Francesco
Demola, Pierluigi
Mantovani, Francesca
Iannaccone, Mario
Manfredi, Roberto
D’Ascenzo, Fabrizio
Fortuni, Federico
Ugo, Fabrizio
Meucci, Francesco
Navazio, Alessandro
Boccuzzi, Giacomo
Efficacy and safety of left atrial appendage closure compared with oral anticoagulation in atrial fibrillation: a meta-analysis of randomized controlled trials and propensity-matched studies
title Efficacy and safety of left atrial appendage closure compared with oral anticoagulation in atrial fibrillation: a meta-analysis of randomized controlled trials and propensity-matched studies
title_full Efficacy and safety of left atrial appendage closure compared with oral anticoagulation in atrial fibrillation: a meta-analysis of randomized controlled trials and propensity-matched studies
title_fullStr Efficacy and safety of left atrial appendage closure compared with oral anticoagulation in atrial fibrillation: a meta-analysis of randomized controlled trials and propensity-matched studies
title_full_unstemmed Efficacy and safety of left atrial appendage closure compared with oral anticoagulation in atrial fibrillation: a meta-analysis of randomized controlled trials and propensity-matched studies
title_short Efficacy and safety of left atrial appendage closure compared with oral anticoagulation in atrial fibrillation: a meta-analysis of randomized controlled trials and propensity-matched studies
title_sort efficacy and safety of left atrial appendage closure compared with oral anticoagulation in atrial fibrillation: a meta-analysis of randomized controlled trials and propensity-matched studies
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565038/
https://www.ncbi.nlm.nih.gov/pubmed/37829693
http://dx.doi.org/10.3389/fcvm.2023.1212161
work_keys_str_mv AT franchinluca efficacyandsafetyofleftatrialappendageclosurecomparedwithoralanticoagulationinatrialfibrillationametaanalysisofrandomizedcontrolledtrialsandpropensitymatchedstudies
AT pirolifrancesco efficacyandsafetyofleftatrialappendageclosurecomparedwithoralanticoagulationinatrialfibrillationametaanalysisofrandomizedcontrolledtrialsandpropensitymatchedstudies
AT demolapierluigi efficacyandsafetyofleftatrialappendageclosurecomparedwithoralanticoagulationinatrialfibrillationametaanalysisofrandomizedcontrolledtrialsandpropensitymatchedstudies
AT mantovanifrancesca efficacyandsafetyofleftatrialappendageclosurecomparedwithoralanticoagulationinatrialfibrillationametaanalysisofrandomizedcontrolledtrialsandpropensitymatchedstudies
AT iannacconemario efficacyandsafetyofleftatrialappendageclosurecomparedwithoralanticoagulationinatrialfibrillationametaanalysisofrandomizedcontrolledtrialsandpropensitymatchedstudies
AT manfrediroberto efficacyandsafetyofleftatrialappendageclosurecomparedwithoralanticoagulationinatrialfibrillationametaanalysisofrandomizedcontrolledtrialsandpropensitymatchedstudies
AT dascenzofabrizio efficacyandsafetyofleftatrialappendageclosurecomparedwithoralanticoagulationinatrialfibrillationametaanalysisofrandomizedcontrolledtrialsandpropensitymatchedstudies
AT fortunifederico efficacyandsafetyofleftatrialappendageclosurecomparedwithoralanticoagulationinatrialfibrillationametaanalysisofrandomizedcontrolledtrialsandpropensitymatchedstudies
AT ugofabrizio efficacyandsafetyofleftatrialappendageclosurecomparedwithoralanticoagulationinatrialfibrillationametaanalysisofrandomizedcontrolledtrialsandpropensitymatchedstudies
AT meuccifrancesco efficacyandsafetyofleftatrialappendageclosurecomparedwithoralanticoagulationinatrialfibrillationametaanalysisofrandomizedcontrolledtrialsandpropensitymatchedstudies
AT navazioalessandro efficacyandsafetyofleftatrialappendageclosurecomparedwithoralanticoagulationinatrialfibrillationametaanalysisofrandomizedcontrolledtrialsandpropensitymatchedstudies
AT boccuzzigiacomo efficacyandsafetyofleftatrialappendageclosurecomparedwithoralanticoagulationinatrialfibrillationametaanalysisofrandomizedcontrolledtrialsandpropensitymatchedstudies